logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10117869 B1

PDFFull Text
Date of Patent:
Nov. 06, 2018

Filed:

Mar. 15, 2013

Pde iii inhibitors for treatment of asymptomatic heart failure

Applicants:

Juergen Daemmgen, Ochsenhausen, DE;

Olaf Joens, Ober-Hilbersheim, DE;

Rainer Kleemann, Ingelheim am Rhein, DE;

Christian Troetschel, Waldalgesheim, DE;

Andrea Vollmar, Wissen, DE;

Inventors:

Juergen Daemmgen, Ochsenhausen, DE;

Olaf Joens, Ober-Hilbersheim, DE;

Rainer Kleemann, Ingelheim am Rhein, DE;

Christian Troetschel, Waldalgesheim, DE;

Andrea Vollmar, Wissen, DE;

Assignee:

BOEHRINGER INGELHEIM VETMEDICA GMBH, Ingelheim am Rhein, DE;

Attorney:

Judy Jarecki-Black

Primary Examiner:

Zachary C Howard

Int. Cl.
CPC ...
A61K 31/501 (2006.01); A61K 31/4166 (2006.01); A61K 31/4412 (2006.01); A61K 31/4427 (2006.01); A61K 31/444 (2006.01); A61K 31/341 (2006.01); A61K 31/40 (2006.01); A61K 31/55 (2006.01); A61K 31/7048 (2006.01); A61P 9/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/501 (2013.01); A61K 31/341 (2013.01); A61K 31/40 (2013.01); A61K 31/4166 (2013.01); A61K 31/444 (2013.01); A61K 31/4412 (2013.01); A61K 31/4427 (2013.01); A61K 31/55 (2013.01); A61K 31/7048 (2013.01); A61P 9/04 (2018.01);
Abstract

Phosphodiesterase type III (PDE III) inhibitor or a 'Ca-sensitizing agent' or a pharmaceutically acceptable derivative thereof is used in the preparation of a medication for the reduction of the heart size of a patient suffering from heart failure, and as a medication for the reverse remodeling of the heart of a patient with asymptomatic (occult) heart failure and their delayed onset of clinical symptoms.

Find Patent Forward Citations

Daemmgen, Juergen. (2018). Pde iii inhibitors for treatment of asymptomatic heart failure (U.S. Patent No. 10117869). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10117869

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…